The search found 3772 results.
Press
Imprivata, Inc. Reports Third Quarter 2014 Financial Results
Imprivata achieves record revenues of $25.3 million, a 41% increase over the comparable period of 2013, and increases annual revenue guidance.
Blog
Two-Factor Authentication Considerations for e-Prescribing of Controlled Substances
Make a well-informed decision about which two-factor authentication modalities to introduce to your EPCS process: keep prescriber satisfaction in mind
Blog
Four Steps to Successfully Deploy Your Secure Clinical Communications Solution
Learn how to successfully deploy a new, secure communications platform at your healthcare facility: secure your success by planning proactively
Blog
The Case for Smarter Clinical Workflows
A seasoned physician shares his perspective on critical cardiology care: improved communication technologies can save time and lives. Learn how now.
News
Imprivata's Sean Kelly: Tighter rules for controlled substances require technology to be successful
Blog
How Leading New York Hospitals are Approaching I-STOP Compliance
Learn how leading New York hospitals are critically thinking about, and planning for, I-STOP's mandatory introduction of EPCS processes.
Press
Imprivata OneSign 5.0 Expands Capabilities of Healthcare Industry’s Leading Solution for Authentication Management and Virtual Desktop Access
Latest Version of Imprivata OneSign Improves Scalability and Expands Market-Leading Support for Desktop Virtualization Platforms and Thin/Zero Clients Lexington, Mass.—December 2, 2014—Imprivata® (NYSE: IMPR), a leading provider of authentication, access management and secure communications solutions for the healthcare industry, today introduced Imprivata OneSign® 5.0, the newest version of the company’s flagship authentication and access management solution.
Video
Electronic prescribing of controlled substances: an overview of the benefits and regulatory requirements
This video highlights the benefits of electronic prescribing of controlled substances (EPCS) and provides an overview of the DEA regulatory requirements for EPCS.   
Blog
Six Steps to a Successful e-Prescribing of Controlled Substances Project: Part 1
Electronic prescribing of controlled substances (EPCS) has many benefits for prescribers, patients, IT, and pharmacy and hospital administration. But the DEA requirements for EPCS introduce complexities that need to be considered when developing a project plan.
Video
Methodist Health System’s success with e-Prescribing of controlled substances
Methodist Health System (Omaha, Neb.) leverages fingerprint biometric authentication from Imprivata to enable e-Prescribing of controlled substances to improve patient satisfaction, eliminate dual-prescribing workflows and address drug diversion.